Sertraline increased circulating NEFAs at baseline in our study, potentially consistent with increased serotonin-induced activation of lipolytic 5-HT2B receptors in WAT, particularly as sertraline did not alter other markers of insulin resistance such as insulin or glucose concentrations. Here, INS is linked to Insulin resistance.